Scientific breakthrough leads to 'fluorescent biological qubit' — it could mean turning your cells into quantum sensors

FierceBiotechBayer scraps protein therapy for hypertension from phase 1, along with neuropathic pain drug

BioPharma DiveA year after Vertex’s big launch, pain drug research faces a pivotal moment

Endpoints NewsFlagship startup Serif says it has solved non-viral gene therapy in monkeys

FierceBiotechBlood-based approach could detect early heart, kidney disease, study finds

Endpoints NewsBristol Myers joins Hengrui party in 13-asset deal worth up to $15.2B

AgilentAgilent expands collaboration with C-CAMP to scale access to advanced life sciences analytics - BioSpectrum India

FierceBiotechEnterprise reports phase 2 cystic fibrosis win, succeeding where Big Pharma stumbled

LabiotechThe real reason CGT programs struggle to scale

FierceBiotechBristol Myers Squibb inks $15B biobucks deal to bag Hengrui assets, tap China’s R&D speed

eLifeScience under threat around the world

eLifeFunctional imaging of nine distinct neuronal populations under a miniscope in freely behaving animals

eLifeEndogenous corazonin signaling modulates the post-mating switch in behavior and physiology in females of the brown planthopper and <i>Drosophila</i>